206 related articles for article (PubMed ID: 2362938)
21. Lung adenocarcinoma with bronchioloalveolar carcinoma component is frequently associated with foci of high-grade atypical adenomatous hyperplasia.
Koga T; Hashimoto S; Sugio K; Yonemitsu Y; Nakashima Y; Yoshino I; Matsuo Y; Mojtahedzadeh S; Sugimachi K; Sueishi K
Am J Clin Pathol; 2002 Mar; 117(3):464-70. PubMed ID: 11888087
[TBL] [Abstract][Full Text] [Related]
22. Expression of cyclooxygenase-2, Fas and Fas ligand in pulmonary adenocarcinoma and atypical adenomatous hyperplasia.
Takigawa N; Ida M; Segawa Y; Nakata M; Mandai K; Kishino D; Fujiwara K; Saeki H; Takashima S; Eguchi K
Anticancer Res; 2003; 23(6D):5069-73. PubMed ID: 14981968
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor receptor gene mutation defines distinct subsets among small adenocarcinomas of the lung.
Haneda H; Sasaki H; Shimizu S; Endo K; Suzuki E; Yukiue H; Kobayashi Y; Yano M; Fujii Y
Lung Cancer; 2006 Apr; 52(1):47-52. PubMed ID: 16503085
[TBL] [Abstract][Full Text] [Related]
24. Survivin expression in atypical adenomatous hyperplasia of the lung.
Nakanishi K; Kawai T; Kumaki F; Hiroi S; Mukai M; Ikeda E
Am J Clin Pathol; 2003 Nov; 120(5):712-9. PubMed ID: 14608897
[TBL] [Abstract][Full Text] [Related]
25. Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung.
Kitaguchi S; Takeshima Y; Nishisaka T; Inai K
Hiroshima J Med Sci; 1998 Mar; 47(1):17-25. PubMed ID: 9583279
[TBL] [Abstract][Full Text] [Related]
26. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis.
Sartori G; Cavazza A; Bertolini F; Longo L; Marchioni A; Costantini M; Barbieri F; Migaldi M; Rossi G
Am J Clin Pathol; 2008 Feb; 129(2):202-10. PubMed ID: 18208799
[TBL] [Abstract][Full Text] [Related]
27. Telomere length and telomerase expression in atypical adenomatous hyperplasia and small bronchioloalveolar carcinoma of the lung.
Kawai T; Hiroi S; Nakanishi K; Meeker AK
Am J Clin Pathol; 2007 Feb; 127(2):254-62. PubMed ID: 17210516
[TBL] [Abstract][Full Text] [Related]
28. [Relationship between cellular DNA contents and cell proliferation of non-small cell lung cancer estimated by simultaneous quantification of PCNA and DNA contents by flow cytometer].
Morita K; Hayashi Y; Nagao S; Watanabe Y
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():164-7. PubMed ID: 7611782
[TBL] [Abstract][Full Text] [Related]
29. Atypical adenomatous hyperplasia of the lung and its differentiation from adenocarcinoma. Characterization of atypical cells by morphometry and multivariate cluster analysis.
Mori M; Chiba R; Takahashi T
Cancer; 1993 Oct; 72(8):2331-40. PubMed ID: 8402446
[TBL] [Abstract][Full Text] [Related]
30. Establishment of an immortalized cell line from a precancerous lesion of lung adenocarcinoma, and genes highly expressed in the early stages of lung adenocarcinoma development.
Shimada A; Kano J; Ishiyama T; Okubo C; Iijima T; Morishita Y; Minami Y; Inadome Y; Shu Y; Sugita S; Takeuchi T; Noguchi M
Cancer Sci; 2005 Oct; 96(10):668-75. PubMed ID: 16232198
[TBL] [Abstract][Full Text] [Related]
31. Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma.
Kerr KM; MacKenzie SJ; Ramasami S; Murray GI; Fyfe N; Chapman AD; Nicolson MC; King G
J Pathol; 2004 Jun; 203(2):638-44. PubMed ID: 15141378
[TBL] [Abstract][Full Text] [Related]
32. Relationship of nuclear DNA content to clinicopathologic features in colorectal cancer.
Lanza G; Maestri I; Ballotta MR; Dubini A; Cavazzini L
Mod Pathol; 1994 Feb; 7(2):161-5. PubMed ID: 8008736
[TBL] [Abstract][Full Text] [Related]
33. DNA ploidy and S-phase fraction analyses of hyperplastic, atypical and cancerous endometrium using flow cytometry from paraffin-embedded tissues.
Pervez S; Hitchcock A; Sinton TM; Mani A; Smith JL
Pathol Res Pract; 2002; 198(1):13-7. PubMed ID: 11866205
[TBL] [Abstract][Full Text] [Related]
34. Multiple lung adenocarcinomas and AAH treated by surgical resection.
Seki M; Akasaka Y
Lung Cancer; 2007 Feb; 55(2):237-40. PubMed ID: 17118487
[TBL] [Abstract][Full Text] [Related]
35. [Quantitative analysis of cellular morphometry and DNA content measurement of experimental lung adenocarcinoma].
Huang R; Lu JB; Wang GY
Zhonghua Jie He He Hu Xi Za Zhi; 1994 Oct; 17(5):297-300, 319. PubMed ID: 7712573
[TBL] [Abstract][Full Text] [Related]
36. Analysis of p21Waf1/Cip1 expression in normal, premalignant, and malignant cells during the development of human lung adenocarcinoma.
Hayashi H; Miyamoto H; Ito T; Kameda Y; Nakamura N; Kubota Y; Kitamura H
Am J Pathol; 1997 Aug; 151(2):461-70. PubMed ID: 9250158
[TBL] [Abstract][Full Text] [Related]
37. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues.
Barletta A; Marzullo F; Pellecchia A; Montemurro S; Labriola A; Lomonaco R; Grammatica L; Paradiso A
Anticancer Res; 1998; 18(3A):1677-82. PubMed ID: 9673389
[TBL] [Abstract][Full Text] [Related]
38. DNA ploidy and protein content in bronchioloalveolar carcinoma multi-variable flow cytometry.
Huang MS; Colby TV; Therneau TM; Daly RC; Gonchoroff NJ
Cytometry; 1996 Dec; 26(4):253-9. PubMed ID: 8979023
[TBL] [Abstract][Full Text] [Related]
39. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung.
Yoshida Y; Shibata T; Kokubu A; Tsuta K; Matsuno Y; Kanai Y; Asamura H; Tsuchiya R; Hirohashi S
Lung Cancer; 2005 Oct; 50(1):1-8. PubMed ID: 15950315
[TBL] [Abstract][Full Text] [Related]
40. DNA cytofluorometric and nuclear morphometric analyses of lung adenocarcinoma.
Asamura H; Nakajima T; Mukai K; Noguchi M; Shimosato Y
Cancer; 1989 Oct; 64(8):1657-64. PubMed ID: 2790679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
